Novartis India Ltd

{"amount":25}

{"description":"Novartis India shares jumped ~20% after ChrysCapital and two investors launched an open offer and promoters exited; stock rose past Rs 950 though the open-offer price was Rs 860.64 (3.64% premium).","url":"https://www.msn.com/en-in/money/topstories/novartis-shares-surge-20-after-open-offer-by-chryscapital-2-others-promoter-exit/ar-AA1WHULw?ocid=BingNewsVerp","sentiment":"Positive","domain":"Business Today on MSN"}

{"description":"Feb 20, 2026: Novartis India jumped 20% after Novartis AG agreed to sell 70.68% (1.74 crore shares) to a ChrysCapital-led group. A mandatory open offer at Rs 860.64/share for 26% (64.19 lakh) totals Rs 552.49 crore.","url":"https://money.rediff.com/news/market/novartis-india-stock-surges-on-chryscapital-deal/42351220260220","sentiment":"Positive","domain":"Rediff Money"}

{"description":"Feb 20, 2026: A WaveRise-led buyout agreed to acquire nearly 71% of Novartis India for ₹14.46bn (~$159M), triggering a mandatory open offer at ₹860.84/share; shares rose ~16%.","url":"https://www.morningstar.com/news/dow-jones/202602209/novartis-to-exit-indian-arm-with-stake-sale","sentiment":"Positive","domain":"Morningstar"}

{"description":"Novartis will divest its entire stake in Novartis India to a ChrysCapital-led consortium in a $159 million deal; an open offer has been priced at Rs 860.64 per share.","url":"https://www.business-standard.com/companies/news/swiss-drugmaker-novartis-to-exit-india-listed-unit-in-159-mn-deal-126022000556_1.html","sentiment":"Positive","domain":"Business Standard"}

{"description":"Novartis AG will sell its entire 70.68% stake in Novartis India for ₹1,445.89 crore to a consortium, triggering a mandatory open offer. Shares jumped ~18%; public shareholders can tender 26% at ₹860 per share.","url":"https://www.msn.com/en-in/money/markets/novartis-ag-to-sell-entire-7068-stake-for-144589-crore-in-india-unit-stock-jumps-18/ar-AA1WHV7j?ocid=BingNewsVerp","sentiment":"Positive","domain":"Mint on MSN"}

{"description":"Novartis to sell majority stake in Novartis India in a ₹1,446 crore deal; consortium will pay public shareholders ₹860.64 per share, the company said in an exchange filing.","url":"https://www.business-standard.com/companies/news/novartis-to-sell-majority-stake-in-india-unit-in-1-446-crore-deal-126022000150_1.html","sentiment":"Neutral","domain":"Business Standard"}

{"description":"Novartis India Ltd's promoter is selling its entire 70.68% stake, triggering an open offer at Rs 860.64 per share; the buyer will also remove seller-group references from the company name within 120 days of deal completion.","url":"https://www.msn.com/en-in/money/other/novartis-india-promoter-to-sell-entire-70-68-stake-triggering-open-offer-at-rs-860-64-apiece/ar-AA1WI9iQ?ocid=BingNewsVerp","sentiment":"Neutral","domain":"Business Today on MSN"}

{"description":"On Feb 20, 2026 Novartis AG agreed to sell 70.68% of Novartis India to a ChrysCapital‑led consortium; promoter exit, name to change within 120 days; shares jumped ~17% to ₹974.","url":"https://www.cnbctv18.com/market/novartis-ag-exits-india-arm-sells-71-pc-stake-chryscapital-led-consortium-ws-l-19854180.htm","sentiment":"Positive","domain":"CNBCTV18"}

{"description":"Novartis has agreed to acquire Avidity Biosciences for $12 billion, enhancing its position in the biotech sector. This deal is expected to significantly impact Novartis's portfolio and future growth strategies.","url":"https://www.moneycontrol.com/news/business/novartis-agrees-to-buy-avidity-in-12-billion-biotech-deal-13634432.html","sentiment":"Positive","domain":"Moneycontrol"}